ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

NCI Committed To 50 Percent Mortality Reduction By 2000; DCPC Board Hears How That Will Be Done

January 20, 1984

Funding Opportunities.

April 12, 2002

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

Review Panel: NCI Intramural Program Is Too Large, Redundant, Hierarchical

May 19, 1995

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998